Persistent Asset Partners »

Lb Pharmaceuticals shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $91k 4.1k 22.26

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Vanguard Group
Jpmorgan Chase & Co
Balyasny Asset Management
Jennison Associates
Vivo Capital
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management

View all funds holding Lb Pharmaceuticals